Publication|Articles|July 31, 2024
Supplements and Featured Publications
- Polycythemia Vera Treatment: Health Economic Considerations
Polycythemia Vera Treatment: Health Economic Considerations
Advertisement
This clinical brief highlights the economic impact of polycythemia vera, particularly the costs associated with thrombotic events, and the importance of effective disease management in reducing health care expenses and improving patient outcomes.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Blinatumomab Boosts Survival in Pediatric ALL, but Faces Delivery Hurdles
2
Digital Innovation and New Drugs Converge to Transform CRM Care
3
Advancing Early Detection and Equitable Access in Alzheimer Disease Care
4
Bills to Address Expiring ACA Subsidies Fail to Pass Senate
5





































